Invivyd (IVVD) CSO sells shares to cover taxes on vested RSUs
Rhea-AI Filing Summary
Invivyd, Inc. (IVVD) reported insider equity activity by Chief Scientific Officer Robert D. Allen III relating to restricted stock units (RSUs). On August 15, 2026, 102,000 RSUs, each representing one share of common stock, were converted into 102,000 shares of Invivyd common stock as part of an RSU vesting schedule over eighteen months from a February 15, 2025 grant date. In connection with this vesting, Allen executed non-discretionary "sell-to-cover" transactions under a Rule 10b5-1 plan adopted on February 20, 2025, selling 20,679 shares on August 17, 2026 at a weighted average price of $0.722 and 17,043 shares on August 18, 2026 at a weighted average price of $0.8429 to satisfy tax withholding obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Allen Robert D. III
Role
Chief Scientific Officer
Sold
37,722 shs ($29K)
Approx. gross sale proceeds
$29K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2, F4 | 17,043 | $0.8429 | $14K |
| Sale | Common Stock F2, F3 | 20,679 | $0.722 | $15K |
| Exercise | Restricted Stock Units F1, F5 | 102,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 102,000 | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 178,765 shares (Direct)
Footnotes (5)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
- F2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Key Figures
Shares sold 2026-08-17: 20679 shares
Weighted average price 2026-08-17: $0.722 per share
Shares sold 2026-08-18: 17043 shares
+4 more
7 metrics
Shares sold 2026-08-17
20679 shares
Common stock sold on August 17, 2026 in open-market or private transactions
Weighted average price 2026-08-17
$0.722 per share
Weighted average sale price for 20,679 common shares sold on August 17, 2026
Shares sold 2026-08-18
17043 shares
Common stock sold on August 18, 2026 in open-market or private transactions
Weighted average price 2026-08-18
$0.8429 per share
Weighted average sale price for 17,043 common shares sold on August 18, 2026
RSUs converted
102000 units
Restricted stock units converted into 102,000 shares of common stock on August 15, 2026
RSU vesting period
18 months
RSU award vests one-third every six months from grant date February 15, 2025
Rule 10b5-1 plan adoption date
February 20, 2025
Date the reporting person adopted the Rule 10b5-1 trading plan for sell-to-cover transactions
Key Terms
Restricted Stock Units, Rule 10b5-1 plan, sell-to-cover, weighted average price
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 plan regulatory
"sell-to-cover transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
sell-to-cover financial
"shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transactions did Invivyd (IVVD) report for Robert D. Allen III?
Invivyd reported that Chief Scientific Officer Robert D. Allen III had 102,000 RSUs convert into 102,000 common shares, and then sold 37,722 shares in total over two days to cover tax withholding obligations.
Were the recent Invivyd (IVVD) insider sales under a Rule 10b5-1 plan?
Yes. The filing states the sales were non-discretionary "sell-to-cover" transactions executed pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 20, 2025, in connection with RSU vesting.
What RSU award structure did Invivyd (IVVD) disclose for the insider?
The RSU award for Robert D. Allen III vests over 18 months, with one-third of the 102,000 RSUs vesting every six months following the February 15, 2025 grant date, subject to continuous service.
Do the Invivyd (IVVD) insider sales reflect discretionary selling by the executive?
According to the filing, the reported sales were sell-to-cover transactions to meet tax withholding obligations on vested RSUs and were made under a pre-adopted Rule 10b5-1 trading plan, limiting discretionary timing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
